XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jul. 31, 2022   6,485,309      
Beginning balance at Jul. 31, 2022 $ (9,206) $ 65 $ 7,479,906 $ (7,493,317) $ 4,140
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 4,431     4,431  
Preferred dividends (1,074)     (1,074)  
Restricted stock grants (in shares)   27,324      
Share-based compensation 355   355    
Other comprehensive items 740       740
Ending balance (in shares) at Jan. 31, 2023   6,512,633      
Ending balance at Jan. 31, 2023 (4,754) $ 65 7,480,261 (7,489,960) 4,880
Beginning balance (in shares) at Oct. 31, 2022   6,499,021      
Beginning balance at Oct. 31, 2022 (8,524) $ 65 7,480,083 (7,488,897) 225
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (526)     (526)  
Preferred dividends (537)     (537)  
Restricted stock grants (in shares)   13,612      
Share-based compensation 178   178    
Other comprehensive items 4,655       4,655
Ending balance (in shares) at Jan. 31, 2023   6,512,633      
Ending balance at Jan. 31, 2023 $ (4,754) $ 65 7,480,261 (7,489,960) 4,880
Beginning balance (in shares) at Jul. 31, 2023 6,250,493 6,250,493      
Beginning balance at Jul. 31, 2023 $ 68,624 $ 65 61,534 7,612 (587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 9,782     9,782  
Preferred dividends (1,073)     (1,073)  
Restricted stock grants (in shares)   35,098      
Share-based compensation 297   297    
Other comprehensive items $ (273)       (273)
Ending balance (in shares) at Jan. 31, 2024 6,285,591 6,285,591      
Ending balance at Jan. 31, 2024 $ 77,357 $ 65 61,831 16,321 (860)
Beginning balance (in shares) at Oct. 31, 2023   6,267,230      
Beginning balance at Oct. 31, 2023 71,665 $ 65 61,671 11,512 (1,583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 5,346     5,346  
Preferred dividends (537)     (537)  
Restricted stock grants (in shares)   18,361      
Share-based compensation 160   160    
Other comprehensive items $ 723       723
Ending balance (in shares) at Jan. 31, 2024 6,285,591 6,285,591      
Ending balance at Jan. 31, 2024 $ 77,357 $ 65 $ 61,831 $ 16,321 $ (860)